Statistics
Publications
1
Citations
18
H-Index
1
Active since
2001
Affiliations
GlaxoSmithKline (United States)(Current)
Frye Sv is an author at GlaxoSmithKline (United States) specializing in kinase-targeted prodrugs, pharmacology, and de novo drug design.
Publications per year
2001–2001
1
1
A prodrug approach to the design of cRaf1 kinase inhibitors with improved cellular activity.
Edgar R. Wood, Crosby Rm, S.H. Dickerson et al. · PubMed · 2001 · 18 citations
1–1 of 1